NCT03387956View on ClinicalTrials.gov

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

July 28, 2017

Study Completion Date

August 10, 2017

Conditions
Postoperative Nausea
Interventions
DRUG

Intrathecal atropine

100ug intrathecal atropine will be injected with spinal anesthesia

DRUG

dexamethasone

intravenous 8 mg dexamethasone (2ml).

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03387956 - Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting | Biotech Hunter | Biotech Hunter